Ageno W - Search Results

1

Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials.

Barco S, Virdone S, Götschi A, Ageno W, Arcelus JI, Bingisser R, Colucci G, Cools F, Duerschmied D, Gibbs H, Fumagalli RM, Gerber B, Haas S, Himmelreich JCL, Hobbs R, Hobohm L, Jacobson B, Kayani G, Lopes RD, MacCallum P, Micieli E, Righini M, Robert-Ebadi H, Rocha AT, Rosemann T, Sawhney J, Schellong S, Sebastian T, Spirk D, Stortecky S, Turpie AGG, Voci D, Kucher N, Pieper K, Held U, Kakkar AK; OVID and ETHIC Investigators. Barco S, et al. Among authors: ageno w. Thromb Res. 2023 Oct;230:27-32. doi: 10.1016/j.thromres.2023.08.009. Epub 2023 Aug 18. Thromb Res. 2023. PMID: 37625200 Free article.

2

A randomized comparison of a computer-based dosing program with a manual system to monitor oral anticoagulant therapy.

Ageno W, Turpie AG. Ageno W, et al. Thromb Res. 1998 Sep 1;91(5):237-40. doi: 10.1016/s0049-3848(98)00092-9. Thromb Res. 1998. PMID: 9755836 Clinical Trial. No abstract available.

3

Exaggerated initial response to warfarin following heart valve replacement.

Ageno W, Turpie AG. Ageno W, et al. Am J Cardiol. 1999 Oct 15;84(8):905-8. doi: 10.1016/s0002-9149(99)00463-4. Am J Cardiol. 1999. PMID: 10532508

4

The use of glycoprotein IIb/IIIa receptor inhibitors in unstable angina.

Ageno W, Turpie AG. Ageno W, et al. G Ital Cardiol. 1999 Nov;29(11):1357-65. G Ital Cardiol. 1999. PMID: 10609142 Review. No abstract available.

5

A computer generated induction system for hospitalized patients starting on oral anticoagulant therapy.

Ageno W, Johnson J, Nowacki B, Turpie AG. Ageno W, et al. Thromb Haemost. 2000 Jun;83(6):849-52. Thromb Haemost. 2000. PMID: 10896237 Clinical Trial.

6

Low-molecular-weight heparin in the treatment of pulmonary embolism.

Ageno W, Turpie AG. Ageno W, et al. Semin Vasc Surg. 2000 Sep;13(3):189-93. Semin Vasc Surg. 2000. PMID: 11005462 Review.

7

Therapy of unstable angina with the low molecular weight heparins.

Ageno W, Turpie AG. Ageno W, et al. Vasc Med. 2000;5(4):217-23. Vasc Med. 2000. PMID: 11213233 Review.

8

Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.

Ageno W, Turpie AG, Steidl L, Ambrosini F, Cattaneo R, Codari RL, Nardo B, Venco A. Ageno W, et al. Am J Cardiol. 2001 Jul 1;88(1):40-4. doi: 10.1016/s0002-9149(01)01582-x. Am J Cardiol. 2001. PMID: 11423056 Clinical Trial.

9

New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.

Ageno W, Turpie AG. Ageno W, et al. CMAJ. 2002 Apr 2;166(7):919-24. CMAJ. 2002. PMID: 11949991 Free PMC article. Review. No abstract available.

10

The safety of antithrombotic therapy during pregnancy.

Ageno W, Crotti S, Turpie AG. Ageno W, et al. Expert Opin Drug Saf. 2004 Mar;3(2):113-8. doi: 10.1517/eods.3.2.113.27343. Expert Opin Drug Saf. 2004. PMID: 15006717 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

719 results

Search Page

Filters